Trials / Completed
CompletedNCT00867191
Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)
A Multi-Centre, Double-Blind, Randomised Comparison Of The Effects Of Desloratadine (Aerius®) And Placebo In The Relief Of Nasal Symptom Scores In Subjects With Seasonal Allergic Rhinitis (Sar) To Cypress Pollen
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 233 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to demonstrate the efficacy (% of change from baseline) of desloratadine to improve the nasal total symptom score of SAR to cypress pollen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo, 1 tablet daily, per os., 15 days |
| DRUG | Desloratadine | Desloratadine, one 5 mg tablet daily, per os, 15 days |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2009-03-23
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00867191. Inclusion in this directory is not an endorsement.